tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Srikripa Devarakonda, 119 are a BUY (90.15%), 13 are a HOLD (9.85%).
Analyst Srikripa Devarakonda, currently employed at TRUIST, carries an average stock price target met ratio of 60.25% that have a potential upside of 33.55% achieved within 207 days.
Srikripa Devarakonda’s has documented 263 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AMGN, Amgen at 05-Aug-2026.
Analyst best performing recommendations are on TERN (TERNS PHARMACEUTICALS).
The best stock recommendation documented was for TERN (TERNS PHARMACEUTICALS) at 10/15/2025. The price target of $20 was fulfilled within 27 days with a profit of $11.5 (135.29%) receiving and performance score of 50.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Jul-2026
$150
$30.48 (25.50%)
$125
Hold Since 03-May-2023
$109
$-10.52 (-8.80%)
$99
Buy Since 04-Feb-2026
$139
$19.48 (16.30%)
$134
Hold Since 13-Jul-2026
$130
$10.48 (8.77%)
$112
Hold Since 24-Oct-2022
$110
$-9.52 (-7.97%)
$89
Which stock is Srikripa Devarakonda is most bullish on?
Which stock is Srikripa Devarakonda is most reserved on?
What Year was the first public recommendation made by Srikripa Devarakonda?
